106.7 The Fan All News 99.1 WNEW CBS Sports Radio 1580

FDA OKs 1st Hay Fever Allergy Immunotherapy Tablet

View Comments
File photo of sneezing. (credit: Sean Gallup/Getty Images)

File photo of sneezing. (credit: Sean Gallup/Getty Images)

Latest News

Get Breaking News First

Receive News, Politics, and Entertainment Headlines Each Morning.
Sign Up

WASHINGTON — The U.S. Food and Drug Administration has approved the first tablet for gradually reducing hay fever allergy symptoms, an alternative to uncomfortable allergy-desensitizing shots.

Oralair, a tablet that dissolves quickly under the tongue, is approved for patients aged 10 through 65. It’s to be taken daily starting four months before grass pollen season to reduce allergic reactions to five grass types.

In patient testing, it reduced symptoms and need for medications by up to 30 percent, compared with dummy pills. Common side effects include throat irritation, mouth swelling and the possibility of severe allergic reactions.

Oralair is made by France’s Stallergenes SA.

Meanwhile, drugmaker Merck & Co. of Whitehouse Station, N.J., expects an FDA ruling by midyear on two immunotherapy tablets, one for ragweed and one for grass pollen allergies.

(© Copyright 2014 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.)

 

View Comments
blog comments powered by Disqus
Follow

Get every new post delivered to your Inbox.

Join 1,626 other followers